Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Biomédica (Bogotá) ; 42(4): 562-573, oct.-dic. 2022. tab, graf
Article in Spanish | LILACS | ID: biblio-1420306

ABSTRACT

Los sistemas no lineales no son susceptibles de ser investigados con métodos reduccionistas. En este sentido, la teoría de la complejidad ofrece un enfoque alternativo para cuantificar la importancia de los factores contextuales en el paciente con dolor musculoesquelético. El resultado del uso positivo (placebo) o negativo (nocebo) de factores contextuales en el entorno terapéutico, podría ser responsable de gran parte de un componente inespecífico en la eficacia del tratamiento, afectando directamente la calidad de los resultados relacionados con la salud del paciente (por ejemplo, dolor, funcionalidad o satisfacción). En los últimos años, se ha incrementado la comprensión del valor de estos efectos. A pesar del creciente interés, el conocimiento y el reconocimiento de los efectos terapéuticos, continúan siendo limitados y heterogéneos entre los fisioterapeutas, lo cual reduce su valor traslacional en el campo de la fisioterapia. El propósito de este estudio es presentar el abordaje el paciente con dolor musculoesquelético desde la perspectiva la teoría de la complejidad.


Nonlinear systems are not susceptible to research with a reductionist approach. In this sense, the complexity theory provides an alternative approach to quantify the importance of contextual factors in patients with musculoskeletal pain. The use of positive (placebo) or negative (nocebo) contextual factors in the therapeutic setting could largely account for the non-specific component of treatment efficacy, directly affecting the quality of patients' health-related outcomes (e.g., pain, disability, or satisfaction). In recent years, there has been a better understanding of the effects of contextual factors. However, the knowledge and awareness of them is limited and heterogeneous among physical therapists, reducing their translational value in the field of physiotherapy. The purpose of this essay is to describe the management of patients with musculoskeletal pain from the complexity theory perspective.


Subject(s)
Systems Analysis , Musculoskeletal Pain , Placebos , Physical Therapy Modalities , Nocebo Effect
2.
Rev. CEFAC ; 24(4): e3022, 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1406701

ABSTRACT

ABSTRACT Purpose: to describe the strategies used to minimize the nocebo effect in health communication. Methods: an integrative review of the literature. The keywords "nocebo effect" and "health communication" and their combinations were used in English, Portuguese, and Spanish to search publications from 2011 to 2021 in MEDLINE, Latin American and Caribbean Health Sciences Literature (LILACS), Cochrane Library, EMBASE, and Web of Science/ISI. The following research question was used: "Which strategies have been used to minimize the nocebo effect in health communication?". Literature Review: altogether, 77 articles were found, although only six met the inclusion criteria and comprised the review sample. Their year of publication ranged from 2015 to 2021. Positive framing, assertive communication, and contextual factors were the strategies used to minimize the nocebo effect. Conclusion: the strategies used to minimize the nocebo effect were contextual factors, motivational talk, positive framing, assertive communication, and empathetic communication. These communication techniques are seemingly effective, though still little known by health professionals. This knowledge is important as it helps develop communicative skills aiming at humanized patient care.


RESUMO Objetivo: descrever as estratégias para minimizar o efeito nocebo na comunicação em saúde. Métodos: trata-se de uma revisão integrativa da literatura. Os descritores utilizados foram: "Efeito nocebo" e "comunicação em saúde", em inglês, português e espanhol e suas combinações, no período de 2011 a 2021, nas bases de dados da Medline, Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), Cochrane Library, Embase e Web of Science/ISI. A pergunta de investigação para esse estudo foi: Quais as estratégias utilizadas para minimizar o efeito nocebo na comunicação em saúde? Revisão da Literatura: foram encontrados 77 artigos. Apenas seis preencheram os critérios de inclusão e compuseram a amostra da revisão. Os anos de publicação dos artigos variaram entre 2015 e 2021. As estratégias definidas para minimizar o efeito nocebo foram: enquadramento positivo, comunicação assertiva e utilização de fatores contextuais. Conclusão: as estratégias encontradas para minimizar o efeito nocebo foram fatores contextuais, conversa motivacional, enquadramento positivo, comunicação assertiva e comunicação empática. Essas técnicas de comunicação parecem ser efetivas, mas ainda são pouco conhecidas pelos profissionais em saúde. Esse conhecimento se faz importante, pois auxilia no desenvolvimento de habilidades comunicativas que visam à humanização do cuidado ao paciente.

3.
Rev. méd. Chile ; 146(4): 518-522, abr. 2018.
Article in Spanish | LILACS | ID: biblio-961423

ABSTRACT

When prescribing a treatment, the physician should give truthful information about the likely benefits and the potential adverse effects, allowing the patient to make an autonomous decision about whether to take the treatment. However, the mere expectation of adverse effects may precipitate the corresponding symptoms. This is called "nocebo effect", which in contrast to the placebo effect, can lead to harm to the patient due to psychological factors. Nocebo effects are common and clinically significant, although often unnoticed. This situation generates conflicts in medical ethics guiding principles, namely the moral obligation to disclose all possible effects of the prescribed drug as opposed to the duty of avoiding the harm of side effects that are likely to occur in a case. In other words, the physician faces a dilemma between the due respect for autonomy and the duty of non-maleficence. This article reflects about this conflict, by exploring the limits of the principle of autonomy and how to balance it with the principle of non-maleficence. We suggest an interpretation of the principle of autonomy from a patient-centered perspective, suggesting that it is ethically sound to give a prudential, partial disclosure of information to the patient, for the sake of avoiding potential nocebo effects. The article concludes with some cautionary considerations to be considered about this decision.


Subject(s)
Humans , Disclosure/ethics , Ethical Analysis , Ethics, Medical , Nocebo Effect , Personal Autonomy , Moral Obligations , Decision Making/ethics
4.
Rev. méd. Chile ; 145(6): 775-782, June 2017. tab, graf
Article in Spanish | LILACS | ID: biblio-902543

ABSTRACT

The placebo effect has been seldom studied in the history of medicine. However, during the last decades, the great impact of this phenomenon in clinical practice, ranging from surgical to psychiatric field, has been revealed. Research elucidated both the psychological mechanisms and genetic polymorphisms that affect the susceptibility of individuals to express this phenomenon. We herein review the psychological mechanisms, brain structures (anterior cingulate cortex, nucleus accumbens, dorsolateral prefrontal cortex, insular cortex, thalamus) and neurotransmission systems involved (opioid, dopaminergic, cannabinoid, serotoninergic, cholecystokinin). These are the clue to recognize the polymorphisms that have been identified so far. The biological basis of both the placebo effect and its alter ego, the nocebo effect, are well recognized, and related to corresponding psychological processes. Finally, the implications of the findings in clinical practice and medical training are discussed.


Subject(s)
Placebo Effect , Neurotransmitter Agents/physiology , Pain/physiopathology , Pain/psychology , Prefrontal Cortex/physiology , Neurotransmitter Agents/genetics , Nocebo Effect
5.
Rev. bioét. (Impr.) ; 22(3): 427-433, set.-dez. 2014.
Article in Portuguese | LILACS | ID: lil-732760

ABSTRACT

O respeito ao princípio da autonomia e consentimento informado obriga o médico a explicar ao paciente os efeitos secundários das terapêuticas que prescreve. Entre eles, há o chamado efeito nocebo, cujas especificidades, detalhadas neste artigo a partir da oftalmologia, implica que o fornecimento da informação possa vir a contrariar o princípio da não maleficência a pacientes vulneráveis. O consentimento informado em oftalmologia para drogas off-label traz nova questão ético-jurídica, que este artigo aborda a partir dos riscos do efeito nocebo. O médico tem o dever de esclarecer e o paciente, o direito de ser esclarecido sobre as vantagens, desvantagens, riscos, benefícios de qualquer medicação. O "consentimento informado contextualizado" pretende atenuar a resposta nocebo de modo a preservar tanto a autonomia do paciente quanto a ação não maleficente do médico...


The respect to the principle of autonomy and informed consent obligates physicians to explain patients the possible side effects when prescribing medications. This disclosure may itself induce adverse effects or negative placebo. This fact contradicts the principle of non-maleficence in vulnerable patients as in ophthalmological disease. There is some tension between information to the patient that takes into account possible side effects. The Informed consent to patient for off label drugs used for example in ophthalmology is a new contextualized legal ethical question. This article has for objective to alert to the doctor for the effect risk nocebo. The doctor has the duty to explain and the patient the right to be explained about the advantages, disadvantages, risks and benefits of any medication. The contextualized informed consent suggests a pragmatic approach for providers to minimize nocebo responses while still maintaining patient autonomy through, by means of the form as it informs...


El respeto al principio de la autonomía y consentimiento informado obliga al médico explicar al paciente los efectos secundarios de las terapéuticas prescritas. Entre ellos, existe el llamado efecto nocebo, cuyas especificidades, detalladas en este artículo desde la oftalmología, supone que el suministro de la información pueda contradecirse al principio de la no maleficencia a pacientes vulnerables. El consentimiento informado en oftalmología para drogas off-label trae una nueva cuestión ético-jurídico que plantea este artículo a partir de los riesgos del efecto nocebo. El médico tiene el deber de aclarar y el paciente el derecho de ser aclarado acerca de las ventajas, las desventajas, los riesgos, beneficios de cualquier medicamento. El "consentimiento informado contextualizado" pretende mitigar la respuesta nocebo para preservar tanto la autonomía del paciente cuanto a la acción no maleficente del médico...


Subject(s)
Humans , Male , Female , Drug Prescriptions , Informed Consent , Nocebo Effect , Personal Autonomy , Risk , Therapeutics
SELECTION OF CITATIONS
SEARCH DETAIL